CJC-1295 (NO DAC) + Ipamorelin
Research Peptide Blend
A combination of CJC-1295 (No DAC), a modified GHRH analogue, and Ipamorelin, a ghrelin receptor agonist peptide.
Product information
Composition: 5 mg CJC-1295 (No DAC) + 5 mg Ipamorelin
Total content: 10 mg per vial
Form: Lyophilized powder
Research area
- GHRH and ghrelin receptor signaling pathways
- Receptor binding and signal transduction
- Peptide interactions
- Structure–activity relationships
- Analytical characterization
Research Use Only
Exclusively for laboratory, analytical and scientific research. Not for human or veterinary consumption, self-administration, diagnostic or therapeutic use.
